SERPINB2 and polycystic ovary syndrome: Thepresent research was carried out to study the impact of Plasminogen Activator Inhibitor (PAI-1) 4G/5G polymorphism (rs1799889) inPCOS, and the risk of developing PCOS in South Indian Population.